The MEU has extensive experience in bioequivalence studies in both healthy subjects and patient populations. We have conducted and designed numerous bioequivalence studies for our clients.
We have conducted both single-dose and steady state bioequivalence dependent on the objectives of the study. Furthermore, we have strict guidelines and experience with fed-state bioequivalence studies in terms of fat/protein and carbohydrate content. The MEU do undertake studies in this field which may require specific pharmacodynamic measurements to assess for therapeutic equivalence.